Wave Life Sciences (WVE) FCF Margin (2015 - 2026)
Wave Life Sciences (WVE) posted FCF Margin of 156.86% for Q1 2026, up 70.54% on a QoQ basis from 532.45% in Q2 2025, and up 53202.0% year-over-year from N/an in Q1 2025.
Wave Life Sciences (WVE) FCF Margin (2015 - 2026) Analysis & Trends
Wave Life Sciences' FCF Margin history runs 12 years deep, the most recent figure standing at 156.86% for Q1 2026.
- Quarterly FCF Margin rose 53202.0% year-over-year to 156.86% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 244.02% (up 1331.0% YoY) and the FY2025 annual result came in at 440.5%, down 30018.0% from the prior year.
- FCF Margin was 156.86% for Q1 2026 at Wave Life Sciences, up from 532.45% in the prior quarter.
- Across five years, FCF Margin topped out at 657.69% in Q1 2023 and bottomed at 9158.95% in Q3 2022.
- A 5-year average of 1805.15% and a median of 269.97% in 2024 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2022 — FCF Margin plunged 908130 bps — and 2023, when it surged 908853 bps.
- Wave Life Sciences' FCF Margin stood at 2715.42% in 2022, then surged by 96 bps to 115.62% in 2023, then slipped by 21 bps to 139.75% in 2024, then slumped by 281 bps to 532.45% in 2025, then jumped by 71 bps to 156.86% in 2026.
- Business Quant data shows WVE's FCF Margin at 156.86% in Q1 2026, 532.45% in Q2 2025, and 688.87% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Wave Life Sciences | 1.16 Bn | 612.38 Mn | - | -156.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -156.86% |
| Jun 30, 2025 | -532.45% |
| Mar 31, 2025 | -688.87% |
| Jun 30, 2024 | -139.75% |
| Mar 31, 2024 | -269.97% |
| Dec 31, 2023 | -115.62% |
| Sep 30, 2023 | -70.42% |
| Jun 30, 2023 | -168.86% |
| Mar 31, 2023 | 657.69% |
| Dec 31, 2022 | -2,715.42% |
| Sep 30, 2022 | -9,158.95% |
| Jun 30, 2022 | -7,817.07% |
| Mar 31, 2022 | -2,290.34% |
| Dec 31, 2021 | -399.32% |
| Sep 30, 2021 | -77.65% |
| Jun 30, 2021 | -350.86% |
| Dec 31, 2020 | -338.72% |
| Sep 30, 2020 | -586.58% |
| Jun 30, 2020 | -1,264.65% |
| Mar 31, 2020 | -644.80% |